FibroBiologics FBLG 深 滬
已收盤 08-07 16:00:00 美东时间
0.9762
-0.044
-4.29%
華盛通- 最 高1.0664
- 今 開1.04
- 成交量 17.09万股
- 最 低 0.9602
- 昨 收 1.02
- 總市值 649.97万
- 52周最高 12.80
- 市盈率 靜 --
- 換手率 2.57%
- 52周最低 0.6201
- 委 比 0.57%
- 總股本 665.82万
- 歷史最高 1100.00
- 量 比 0.64
- 振 幅 10.41%
- 歷史最低 0.9602
- 每 手 1
- 風險率 3.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
FibroBiologics 2026年第二季度财报：净亏损410万美元，CYWC628进入临床
FibroBiologics（FBLG）2026年第二季度净亏损约410万美元，研发费用降至170万美元，期末现金约350万美元；CYWC628已启动患者给药，预计下半年公布中期结果。
08-05 06:13
Snap To Rally More Than 217%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham cut the price target for ON Semiconductor Corp (NASDAQ:ON) from $130 to $116. Needham analyst N. Quinn...
08-04 19:52
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $6
HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and lowers the price target from $8 to $6.
08-04 18:15
FibroBiologics shares are trading higher after the company reported better-than-expected Q2 EPS results.
FibroBiologics shares are trading higher after the company reported better-than-expected Q2 EPS results.
08-04 02:02
FibroBiologics, Inc. - Common Stock Q2 EPS $(0.66) Beats $(0.72) Estimate
FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.72) by 8.33 percent. This is a 72.5 percent increase over losses of $(2.40) per share from the same period last year.
08-01 05:38
FibroBiologics Faces Nasdaq Delisting, Appeals Planned
FibroBiologics, Inc. ( ($FBLG) ) just unveiled an announcement. On July 22, 202...
07-25 04:37
FibroBiologics Appoints NASA Scientist Kate Rubins to Board
The latest update is out from FibroBiologics, Inc. ( ($FBLG) ). On July 2, 2026...
07-09 21:58
FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors
Microbiologist, Retired NASA Astronaut, and Founding Director of the University of Pittsburgh Trivedi Institute for Space and Global Biomedicine Joins Board HOUSTON, July 9, 2026 /PRNewswire...
07-09 20:30
